Multidrug-resistant Acinetobacter baumannii strains with NDM-1: Molecular characterization and in vitro efficacy of

Jingjing Wang1, Yongzhong Ning2, Shu Li3

  • 1Department of Laboratory Medicine, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471000, P.R. China.

Insights

Combination therapies show promise against multidrug-resistant Acinetobacter baumannii. Meropenem combined with vancomycin, tazobactam, ampicillin-sulbactam, or colistin demonstrated synergistic effects, offering new treatment options for NDM-1 positive infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Acinetobacter baumannii is a major cause of hospital-acquired, multidrug-resistant (MDR) infections globally.
  • Combination antimicrobial regimens are often the only viable treatment for MDR A. baumannii infections.
  • The New Delhi metallo-beta-lactamase 1 (NDM-1) enzyme confers resistance to carbapenems, a critical class of antibiotics.

Purpose of the Study:

  • To evaluate the efficacy of meropenem combined with colistin, ampicillin-sulbactam, tazobactam, and vancomycin against clinical MDR A. baumannii strains.
  • To characterize antimicrobial resistance genes and the genetic background of NDM-1 in these strains.
  • To identify synergistic drug effects in combination therapies.

Main Methods:

  • Antimicrobial susceptibility testing was performed.
  • Resistance genes were identified using multiplex PCR-reverse line blot assay.
  • NDM-1 presence and genetic background were analyzed using primer walking, modified Hodge test, and EDTA-combined disk test.
  • Synergistic effects were screened using checkerboard assays to calculate the fractional inhibitory concentration index.

Main Results:

  • Five MDR A. baumannii strains carrying multiple resistance genes were identified.
  • Synergistic effects were observed for meropenem + vancomycin, meropenem + tazobactam, and meropenem + ampicillin + sulbactam (in two strains each), and meropenem + colistin (in four strains).
  • The NDM-1 gene was found integrated in a transposon structure with the ISAba125 insertion sequence, though genetic backgrounds varied.

Conclusions:

  • Meropenem-based combination therapies, particularly with colistin, vancomycin, tazobactam, and ampicillin-sulbactam, show synergistic activity against MDR A. baumannii strains.
  • The genetic variability of NDM-1, often associated with ISAba125, may contribute to its rapid dissemination.
  • Meropenem may enhance the efficacy of other antibiotics in NDM-1-positive MDR A. baumannii infections.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
870
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.1K